Skip to content

Homeopathic medicines for adult patients with mild hypothyroidism, fatigue, weight gain, constipation, dry skin, and cold intolerance.

A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in the treatment of subclinical hypothyroidism in adults - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093558
Enrollment
110
Registered
2025-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E03- Other hypothyroidism

Interventions

Sponsors

D. N. De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from newly diagnosed subclinical hypothyroidism [ICD 11- 5A00.Z] 2. Serum TSH between 4.5 to 10 mIU/L, with normal T4 levels confirmed with biochemical investigation. 3. Age between 18 and 65 years 4. Patients of either sex, transgender.

Exclusion criteria

Exclusion criteria: 1. Not providing written informed consent for participation. 2. Diagnosed clinical cases of hypothyroidism 3. Vulnerable population?unconscious, ambulatory, too sick for consultation, disabled, terminally ill or critically ill patients; institutionalized subjects, mentally incompetent people 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 5. Pregnant and puerperal women, lactating mothers 6. Patient under tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 7. Self-reported immune-compromised state 8. Already undergoing homoeopathic treatment for chronic disease within last 6 months. 9. Simultaneous participation in any other clinical trials.

Design outcomes

Primary

MeasureTime frame
Serum TSH levelTimepoint: At baseline and after 3 months

Secondary

MeasureTime frame
Blood T3 and T4 levelsTimepoint: At baseline and after 3 months;Thyroid-related quality of life (ThyPRO) questionnaireTimepoint: At baseline, monthly, up to 3 months;Zuleswki?s clinical score (ZCS) for hypothyroidismTimepoint: At baseline, monthly, up to 3 months;Measure Yourself Medical Outcome Profile version 2.0 (MYMOP-2)Timepoint: At baseline, monthly, up to 3 months

Countries

India

Contacts

Public ContactMohan Giri

D N De Homoeopathic Medical College and Hospital

Sagars.kvcob05@gmail.com8900433766

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026